What is STAAR Surgical Company's share price today?
STAAR Surgical Company (STAA) share price today is $26.72 as of November 6, 2026 at 2:29 AM IST. The stock touched a day high of $29.34 and a day low of $25.97.What exchange does STAAR Surgical Company stock trade on, and under what ticker symbol?
STAAR Surgical Company stock trades on NASDAQ under the ticker symbol STAA.What is STAAR Surgical Company's market capitalization?
STAAR Surgical Company's market capitalization is $1.26B as of November 6, 2026 at 2:29 AM IST.What is STAAR Surgical Company's price-to-earnings (P/E) ratio?
STAAR Surgical Company's price-to-earnings (P/E) ratio is 314.62 as of November 5, 2026.What is STAAR Surgical Company's price-to-book (P/B) ratio?
STAAR Surgical Company's price-to-book (P/B) ratio is 3.42 as of November 5, 2026.Can Indian investors buy STAAR Surgical Company shares?
Yes, You can buy STAAR Surgical Company shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in STAAR Surgical Company shares from India?
Indian investors can buy STAAR Surgical Company shares in three steps: 1. Search STAAR Surgical Company on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from STAAR Surgical Company shares for Indian investors?
Since STAAR Surgical Company trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in STAAR Surgical Company shares via Tickertape?
Indian investors can start investing in STAAR Surgical Company (STAA) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.3742 shares at the current price of $26.72.
$
₹
$26.721.65% (-0.45)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
314.62
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
3.42
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$0.08
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
0.76
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
1.13%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Based on 11 analysts reports
Buy4 analysts
Hold6 analysts
Sell1 analyst
Price Upside
+3.54%
Earnings Growth
+202.19%
Rev. Growth
+39.61%
Company Profile
Company Profile
P/E Ratio
85.22
85.22
1Y Return
3.02%
3.02%
Buy Reco %
85.18
85.18
P/E Ratio
45.67
45.67
1Y Return
38.53%
38.53%
Buy Reco %
93.75
93.75
P/E Ratio
21.04
21.04
1Y Return
6.47%
6.47%
Buy Reco %
35.29
35.29
P/E Ratio
22.45
22.45
1Y Return
20.18%
20.18%
Buy Reco %
50.00
50.00
P/E Ratio
—
—
1Y Return
30.95%
30.95%
Buy Reco %
46.66
46.66
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
2026
Current$26.72Baseline
Analyst Target - 1 year
Target$27.67+3.54%
All values in $
2026
Current$26.72Baseline
Analyst Target - 1 year
Target$27.67+3.54%
All values in $
Revenue Forecast
Revenue Forecast
Higher revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.
The next fiscal year's mean estimate implies 39.61% growth, versus a trailing 3-year CAGR of -5.57%.
2025
Current$239.44Baseline
Forecast for Dec 2026
High$346.6+44.75%
Average$334.29+39.61%
Low$325.5+35.94%
All values in $ Million
2025
Current$239.44Baseline
Forecast for Dec 2026
High$346.6+44.75%
Average$334.29+39.61%
Low$325.5+35.94%
All values in $ Million
Earnings Per Share Forecast
Earnings Per Share Forecast
2025
Current$-0.82Baseline
Forecast for Dec 2026
High$1.07+230.17%
Average$0.84+202.19%
Low$0.4+148.66%
All values in $
2025
Current$-0.82Baseline
Forecast for Dec 2026
High$1.07+230.17%
Average$0.84+202.19%
Low$0.4+148.66%
All values in $
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
| Financial Year | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 77.35 | 99 | 88.59 | 48.95 | 42.58 | 44.32 | 94.73 | 57.80 | 93.52 | 93.53 |
Gross Profit | 61.03 | 78.41 | 68.48 | 31.64 | 28 | 32.79 | 77.87 | 43.74 | 67.52 | 69.72 |
| Net Income | -3.33 | 7.37 | 9.98 | -34.22 | -54.21 | -16.81 | 8.88 | -18.30 | 5.20 | 8.05 |
| Net Profit Margin | -4.31% | 7.45% | 11.26% | -69.92% | -127.28% | -37.93% | 9.37% | -31.67% | 5.56% | 8.61% |
Peers
Peers & Comparison
Peers & Comparison
Comparing 2 stocks from
HealthcareMedical Instruments & Supplies
HealthcareMedical Instruments & Supplies
Valuation
Returns
Forecast
Compare valuation on Screener| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| STAAR Surgical Company | 314.62 | 3.42 | 0.76 |
| Medline Inc. Class A Common Stock | 85.22 | 2.55 | - |
| West Pharmaceutical Services Inc | 45.67 | 9.57 | 2.96 |
Price Comparison
Price Comparison
Compare STAA with any stock or ETFCompare STAA with any stock or ETF
Comparing from
STAA
MDLN
WST
The 12-month consensus target implies 3.54% growth, versus a trailing 3-year CAGR of -8.17%.